Cyclerion Therapeutics (CYCN) EBIT Growth (1y) (2019 - 2025)
Cyclerion Therapeutics (CYCN) EBIT Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Cyclerion Therapeutics |
11.50 Mn |
8.26 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
10.82% |
| Jun 30, 2025 |
-20.81% |
| Mar 31, 2025 |
9.95% |
| Dec 31, 2024 |
127.97% |
| Sep 30, 2024 |
81.25% |
| Jun 30, 2024 |
25.79% |
| Mar 31, 2024 |
50.60% |
| Dec 31, 2023 |
59.71% |
| Sep 30, 2023 |
-33.13% |
| Jun 30, 2023 |
86.12% |
| Mar 31, 2023 |
74.78% |
| Dec 31, 2022 |
68.93% |
| Sep 30, 2022 |
59.96% |
| Jun 30, 2022 |
16.96% |
| Mar 31, 2022 |
3.07% |
| Dec 31, 2021 |
25.42% |
| Sep 30, 2021 |
48.19% |
| Jun 30, 2021 |
17.77% |
| Mar 31, 2021 |
34.94% |
| Dec 31, 2020 |
27.69% |
